Nef Neutralizes the Ability of Exosomes from CD4+ T Cells to Act as Decoys during HIV-1 Infection

Nef is an HIV-1 accessory protein that promotes viral replication and pathogenesis. A key function of Nef is to ensure sustained depletion of CD4 and MHC-I molecules in infected cells by inducing targeting of these proteins to multivesicular bodies (MVBs), and ultimately to lysosomes for degradation. Nef also affects cellular secretory routes promoting its own secretion via exosomes. To better understand the effects of Nef on the exocytic pathway, we investigated whether this viral factor modifies the composition of exosomes released by T lymphocytes. We showed that both CD4 and MHC-I molecules are secreted in exosomes from T cells and that the expression of Nef reduces the amount of these proteins in exosomes. To investigate the functional role for this novel activity of Nef, we performed in vitro HIV-1 infection assays in the presence of distinct populations of exosomes. We demonstrated that exosomes released by CD4+ T cells, but not CD4− T cells, efficiently inhibit HIV-1 infection in vitro. Because CD4 is the main receptor for HIV-1 infection, these results suggest that CD4 molecules displayed on the surface of exosomes can bind to envelope proteins of HIV-1 hindering virus interaction with target cells and infection. Importantly, CD4-depleted exosomes released by CD4+ T cells expressing Nef have a reduced capacity to inhibit HIV-1 infection in vitro. These results provide evidence that Nef promotes HIV-1 infection by reducing the expression of CD4 in exosomes from infected cells, besides the original role of Nef in reducing the CD4 levels at the cell surface.

[1]  J. Bonifacino,et al.  Interaction of HIV-1 Nef Protein with the Host Protein Alix Promotes Lysosomal Targeting of CD4 Receptor* , 2014, The Journal of Biological Chemistry.

[2]  Michael Loran Dustin T-cells play the classics with a different spin , 2014, Molecular biology of the cell.

[3]  M. Moser Faculty Opinions recommendation of Polarized release of T-cell-receptor-enriched microvesicles at the immunological synapse. , 2014 .

[4]  G. Melikyan HIV entry: a game of hide-and-fuse? , 2014, Current opinion in virology.

[5]  J. Bonifacino,et al.  How HIV-1 Nef hijacks the AP-2 clathrin adaptor to downregulate CD4 , 2014, eLife.

[6]  S. Gabrielsson,et al.  Exosomes from breast milk inhibit HIV-1 infection of dendritic cells and subsequent viral transfer to CD4+ T cells , 2014, AIDS.

[7]  F. Chisari,et al.  Short-range exosomal transfer of viral RNA from infected cells to plasmacytoid dendritic cells triggers innate immunity. , 2012, Cell host & microbe.

[8]  Y. Igarashi,et al.  Sphingolipid-modulated Exosome Secretion Promotes Clearance of Amyloid-β by Microglia , 2012, The Journal of Biological Chemistry.

[9]  K. Collins,et al.  ADP Ribosylation Factor 1 Activity Is Required To Recruit AP-1 to the Major Histocompatibility Complex Class I (MHC-I) Cytoplasmic Tail and Disrupt MHC-I Trafficking in HIV-1-Infected Primary T Cells , 2011, Journal of Virology.

[10]  A. Baur HIV-Nef and AIDS pathogenesis: are we barking up the wrong tree? , 2011, Trends in microbiology.

[11]  Tracey M. Filzen,et al.  HIV-1 Nef Disrupts Intracellular Trafficking of Major Histocompatibility Complex Class I, CD4, CD8, and CD28 by Distinct Pathways That Share Common Elements , 2011, Journal of Virology.

[12]  M. Caplan,et al.  Exosome release of β-catenin: a novel mechanism that antagonizes Wnt signaling , 2010, The Journal of cell biology.

[13]  J. Jacobson,et al.  Ibalizumab: an anti-CD4 monoclonal antibody for the treatment of HIV-1 infection. , 2010, The Journal of antimicrobial chemotherapy.

[14]  Y. Matsuki,et al.  Secretory Mechanisms and Intercellular Transfer of MicroRNAs in Living Cells*♦ , 2010, The Journal of Biological Chemistry.

[15]  G. Cagney,et al.  HIV Nef is Secreted in Exosomes and Triggers Apoptosis in Bystander CD4+ T Cells , 2010, Traffic.

[16]  S. Mathivanan,et al.  ExoCarta: A compendium of exosomal proteins and RNA , 2009, Proteomics.

[17]  V. Vullo,et al.  Massive secretion by T cells is caused by HIV Nef in infected cells and by Nef transfer to bystander cells. , 2009, Cell host & microbe.

[18]  C. Théry,et al.  Membrane vesicles as conveyors of immune responses , 2009, Nature Reviews Immunology.

[19]  R. Sougrat,et al.  Human Immunodeficiency Virus Type 1 Nef Protein Targets CD4 to the Multivesicular Body Pathway , 2009, Journal of Virology.

[20]  J. Sodroski,et al.  Soluble CD4 and CD4-Mimetic Compounds Inhibit HIV-1 Infection by Induction of a Short-Lived Activated State , 2009, PLoS pathogens.

[21]  O. W. Lindwasser,et al.  A Basic Patch on α-Adaptin Is Required for Binding of Human Immunodeficiency Virus Type 1 Nef and Cooperative Assembly of a CD4-Nef-AP-2 Complex , 2009, Journal of Virology.

[22]  J. Garcia,et al.  HIV-1 Nef: at the crossroads , 2008, Retrovirology.

[23]  K. Collins,et al.  HIV-1 Nef Targets MHC-I and CD4 for Degradation Via a Final Common β-COP–Dependent Pathway in T Cells , 2008, PLoS pathogens.

[24]  Robert T. Youker,et al.  HIV-1 Nef Binds PACS-2 to Assemble a Multikinase Cascade That Triggers Major Histocompatibility Complex Class I (MHC-I) Down-regulation , 2008, Journal of Biological Chemistry.

[25]  C. Oliver,et al.  The low affinity IgG receptor Fc gamma RIIB contributes to the binding of the mast cell specific antibody, mAb BGD6. , 2008, Molecular immunology.

[26]  Sanchita Bhatnagar,et al.  Exosome Function: From Tumor Immunology to Pathogen Biology , 2008, Traffic.

[27]  Petra Schwille,et al.  Ceramide Triggers Budding of Exosome Vesicles into Multivesicular Endosomes , 2008, Science.

[28]  K. Collins,et al.  The Tyrosine Binding Pocket in the Adaptor Protein 1 (AP-1) μ1 Subunit Is Necessary for Nef to Recruit AP-1 to the Major Histocompatibility Complex Class I Cytoplasmic Tail* , 2008, Journal of Biological Chemistry.

[29]  A. Tanuri,et al.  Vpr.A3A Chimera Inhibits HIV Replication* , 2008, Journal of Biological Chemistry.

[30]  J. Hurley,et al.  ESCRT complexes and the biogenesis of multivesicular bodies. , 2008, Current opinion in cell biology.

[31]  John C. Guatelli,et al.  Cooperative Binding of the Class I Major Histocompatibility Complex Cytoplasmic Domain and Human Immunodeficiency Virus Type 1 Nef to the Endosomal AP-1 Complex via Its μ Subunit , 2007, Journal of Virology.

[32]  P. Lehner,et al.  HIV-1 Nef-induced down-regulation of MHC class I requires AP-1 and clathrin but not PACS-1 and is impeded by AP-2. , 2007, Molecular biology of the cell.

[33]  K. Shokat,et al.  HIV-1 Nef assembles a Src family kinase-ZAP-70/Syk-PI3K cascade to downregulate cell-surface MHC-I. , 2007, Cell host & microbe.

[34]  S. Simon,et al.  Dynamic Interaction of HIV‐1 Nef with the Clathrin‐Mediated Endocytic Pathway at the Plasma Membrane , 2007, Traffic.

[35]  A. Tanuri,et al.  Interactions between Nef and AIP1 proliferate multivesicular bodies and facilitate egress of HIV-1 , 2006, Retrovirology.

[36]  K. Collins,et al.  Human Immunodeficiency Virus Type 1 Nef: Adapting to Intracellular Trafficking Pathways , 2006, Microbiology and Molecular Biology Reviews.

[37]  A. Booth,et al.  Exosomes and HIV Gag bud from endosome-like domains of the T cell plasma membrane , 2006, The Journal of cell biology.

[38]  Aled Clayton,et al.  Isolation and Characterization of Exosomes from Cell Culture Supernatants and Biological Fluids , 2006, Current protocols in cell biology.

[39]  Sibel Akyol,et al.  Pregnancy-Associated Exosomes and Their Modulation of T Cell Signaling1 , 2006, The Journal of Immunology.

[40]  Graça Raposo,et al.  Exosomal-like vesicles are present in human blood plasma. , 2005, International immunology.

[41]  John Guatelli,et al.  Nef-induced Alteration of the Early/Recycling Endosomal Compartment Correlates with Enhancement of HIV-1 Infectivity* , 2005, Journal of Biological Chemistry.

[42]  Tracey M. Filzen,et al.  HIV-1 Nef disrupts MHC-I trafficking by recruiting AP-1 to the MHC-I cytoplasmic tail , 2004, The Journal of cell biology.

[43]  Stefan Matile,et al.  Role of LBPA and Alix in Multivesicular Liposome Formation and Endosome Organization , 2004, Science.

[44]  P. Benaroch,et al.  Human immunodeficiency virus-1 Nef expression induces intracellular accumulation of multivesicular bodies and major histocompatibility complex class II complexes: potential role of phosphatidylinositol 3-kinase. , 2003, Molecular biology of the cell.

[45]  G. Thomas,et al.  HIV-1 Nef Downregulates MHC-I by a PACS-1- and PI3K-Regulated ARF6 Endocytic Pathway , 2002, Cell.

[46]  S. Emr,et al.  Receptor downregulation and multivesicular-body sorting , 2002, Nature Reviews Molecular Cell Biology.

[47]  Masashi Yamada,et al.  Maternal Pumilio acts together with Nanos in germline development in Drosophila embryos , 1999, Nature Cell Biology.

[48]  D. Trono,et al.  Cell-surface expression of CD4 reduces HIV-1 infectivity by blocking Env incorporation in a Nef- and Vpu-inhibitable manner , 1999, Current Biology.

[49]  R. Parton,et al.  A lipid associated with the antiphospholipid syndrome regulates endosome structure and function , 1998, Nature.

[50]  B. Walker,et al.  HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes , 1998, Nature.

[51]  M. Greenberg,et al.  Co‐localization of HIV‐1 Nef with the AP‐2 adaptor protein complex correlates with Nef‐induced CD4 down‐regulation , 1997, The EMBO journal.

[52]  E. Kremmer,et al.  Association of human immunodeficiency virus Nef protein with actin is myristoylation dependent and influences its subcellular localization. , 1997, European journal of biochemistry.

[53]  C. Doyle,et al.  Nef proteins encoded by human and simian immunodeficiency viruses induce the accumulation of endosomes and lysosomes in human T cells. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[54]  T. Greenough,et al.  High frequency of defective nef alleles in a long-term survivor with nonprogressive human immunodeficiency virus type 1 infection , 1996, Journal of virology.

[55]  J. S. Sullivan,et al.  Genomic Structure of an Attenuated Quasi Species of HIV-1 from a Blood Transfusion Donor and Recipients , 1995, Science.

[56]  John L. Sullivan,et al.  Absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection , 1995 .

[57]  S. Rhee,et al.  Human immunodeficiency virus type 1 Nef-induced down-modulation of CD4 is due to rapid internalization and degradation of surface CD4 , 1994, Journal of Virology.

[58]  M. Lenburg,et al.  The cytoplasmic domain of CD4 is sufficient for its down-regulation from the cell surface by human immunodeficiency virus type 1 Nef , 1994, Journal of virology.

[59]  B. Cullen,et al.  The simian immunodeficiency virus Nef protein promotes degradation of CD4 in human T cells. , 1994, The Journal of biological chemistry.

[60]  M. Warmerdam,et al.  The human immunodeficiency virus-1 nef gene product: a positive factor for viral infection and replication in primary lymphocytes and macrophages , 1994, The Journal of experimental medicine.

[61]  R. Swanstrom,et al.  Analysis of human immunodeficiency virus type 1 nef gene sequences present in vivo , 1993, Journal of virology.

[62]  B. Cullen,et al.  Downregulation of cell-surface CD4 expression by simian immunodeficiency virus Nef prevents viral super infection , 1993, The Journal of experimental medicine.

[63]  J. Mcdougal,et al.  Two mechanisms of soluble CD4 (sCD4)-mediated inhibition of human immunodeficiency virus type 1 (HIV-1) infectivity and their relation to primary HIV-1 isolates with reduced sensitivity to sCD4 , 1993, Journal of virology.

[64]  D. Baltimore,et al.  Kinetics of expression of multiply spliced RNA in early human immunodeficiency virus type 1 infection of lymphocytes and monocytes. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[65]  R. Desrosiers,et al.  Importance of the nef gene for maintenance of high virus loads and for development of AIDS , 1991, Cell.

[66]  Q. Sattentau,et al.  Direct measurement of soluble CD4 binding to human immunodeficiency virus type 1 virions: gp120 dissociation and its implications for virus-cell binding and fusion reactions and their neutralization by soluble CD4 , 1991, Journal of virology.

[67]  D. Ho,et al.  High concentrations of recombinant soluble CD4 are required to neutralize primary human immunodeficiency virus type 1 isolates. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[68]  D. Richman,et al.  HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy. , 1989, Science.

[69]  A. Fauci,et al.  Induction of HTLV-III/LAV from a nonvirus-producing T-cell line: implications for latency. , 1986, Science.

[70]  N. Yamamoto,et al.  Infection of HTLV-III/LAV in HTLV-I-carrying cells MT-2 and MT-4 and application in a plaque assay. , 1985, Science.

[71]  K. Sell,et al.  Characterization of a continuous T-cell line susceptible to the cytopathic effects of the acquired immunodeficiency syndrome (AIDS)-associated retrovirus. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[72]  E. Reynolds THE USE OF LEAD CITRATE AT HIGH pH AS AN ELECTRON-OPAQUE STAIN IN ELECTRON MICROSCOPY , 1963, The Journal of cell biology.

[73]  J. Gruenberg,et al.  ALIX and the multivesicular endosome: ALIX in Wonderland. , 2014, Trends in cell biology.

[74]  R. Doms,et al.  HIV-1 coreceptors and their inhibitors. , 2006, Current topics in microbiology and immunology.

[75]  R. Palmiter,et al.  Late endosomal membranes rich in lysobisphosphatidic acid regulate cholesterol transport , 1999, Nature Cell Biology.

[76]  J L Sullivan,et al.  Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection. , 1995, The New England journal of medicine.